Compare Two Stocks
Valuation, growth, earnings reaction and guidance credibility, side by sideLLYLilly (Eli)
FinDog View：Bullish
| Metric | LLY | MRNA |
|---|
| Close | 1,137.82 | 145.62 |
| Market Cap | $1.07T | $58.1B |
| 1M | −3.83% | +125.91% |
| P/E (TTM) | 39.9 | — |
| Forward P/E | 28.5 | — |
| P/E 5-Yr Percentile | 6 | — |
| P/S | 13.4 | 25.8 |
| P/B | 31.5 | 8.5 |
| Dividend Yield | 0.75% | — |
| Latest Quarter Revenue | $23.0B | $145M |
| Revenue YoY | +47.7% | +2.1% |
| Gross Margin | 85.8% | 35.9% |
| Latest Quarter EPS | 7.94 | -1.97 |
| Avg Post-Earnings Move | ±3.5% | ±4.2% |
| EPS Beat Rate | — | — |
| Guidance Hit Rate | — | — |
| Shareholder Yield | 1.12% | — |
| 90-Day Net Insider Buying | −$16.0M | −$49.2M |
LLY · Revenue, Last 8 Quarters ($B)
MRNA · Revenue, Last 8 Quarters ($B)
